Hydrodynamic and functional analysis of HIV-1 Vif oligomerization

Biochemistry

Volumn 51, Issue 10, 2012, Pages 2078-2086

  Techtmann, Stephen M ^a   Ghirlando, Rodolfo ^b   Kao, Sandra ^c   Strebel, Klaus ^c   Maynard, Ernest L ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ULTRACENTRIFUGATION; APOLIPOPROTEIN B; C-TERMINUS; COMPLEX MECHANISMS; CYTIDINE DEAMINASE; N-TERMINALS; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASES; VIRAL GENOME;

CENTRIFUGATION; DEGRADATION; OLIGOMERIZATION;

OLIGOMERS;

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MUTANT PROTEIN; OLIGOMER; POLYPEPTIDE; THREONYLPROLYLLYSYLLYSYLISOLEUCYLLYSYLPROLYLPROLYLLEUCYLPROLYLSERYLVALYLTHREONYLLYSYLLEUCYLTHREONYLGLUTAMYLASPARTYLARGINYLTRYPTOPHYLASPARAGINYLLYSINE; UNCLASSIFIED DRUG; VIF PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDRODYNAMICS; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; BINDING SITES; CYTIDINE DEAMINASE; HELA CELLS; HUMANS; HYDRODYNAMICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84858216657     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi201738a     Document Type: Article

References (69)

1. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418, 646-650
2. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S. J., and Malim, M. H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr. Biol. 14, 1392-1396 (Pubitemid 39081643)
3. Liddament, M. T., Brown, W. L., Schumacher, A. J., and Harris, R. S. (2004) APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr. Biol. 14, 1385-1391 (Pubitemid 39081642)
4. Wiegand, H. L., Doehle, B. P., Bogerd, H. P., and Cullen, B. R. (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J. 23, 2451-2458 (Pubitemid 38954852)
5. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peterlin, B. M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78, 6073-6076 (Pubitemid 38661697)
6. Luo, K., Liu, B., Xiao, Z., Yu, Y., Yu, X., Gorelick, R., and Yu, X. F. (2004) Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging J. Virol. 78, 11841-11852 (Pubitemid 39390771)
7. Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., and Kleiman, L. (2004) The interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem. 279, 33177-33184 (Pubitemid 39062962)
8. Alce, T. M. and Popik, W. (2004) APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein J. Biol. Chem. 279, 34083-34086 (Pubitemid 39318027)
9. Douaisi, M., Dussart, S., Courcoul, M., Bessou, G., Vigne, R., and Decroly, E. (2004) HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles Biochem. Biophys. Res. Commun. 321, 566-573 (Pubitemid 39118379)
10. Schafer, A., Bogerd, H. P., and Cullen, B. R. (2004) Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328, 163-168 (Pubitemid 39349465)
11. Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W. S., and Pathak, V. K. (2004) Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs J. Biol. Chem. 279, 35822-35828 (Pubitemid 39100589)
12. Zennou, V., Perez-Caballero, D., Gottlinger, H., and Bieniasz, P. D. (2004) APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78, 12058-12061 (Pubitemid 39390791)
13. Khan, M. A., Kao, S., Miyagi, E., Takeuchi, H., Goila-Gaur, R., Opi, S., Gipson, C. L., Parslow, T. G., Ly, H., and Strebel, K. (2005) Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes J. Virol. 79, 5870-5874 (Pubitemid 40548257)
14. Navarro, F., Bollman, B., Chen, H., Konig, R., Yu, Q., Chiles, K., and Landau, N. R. (2005) Complementary function of the two catalytic domains of APOBEC3G Virology 333, 374-386 (Pubitemid 40250119)
15. Burnett, A. and Spearman, P. (2007) APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker J. Virol. 81, 5000-5013 (Pubitemid 46744412)
16. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003) DNA deamination mediates innate immunity to retroviral infection Cell 113, 803-809 (Pubitemid 36724943)
17. Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A. J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein Science 300, 1112 (Pubitemid 36583087)
18. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424, 99-103 (Pubitemid 36834849)
19. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H., and Landau, N. R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114, 21-31 (Pubitemid 36859838)
20. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424, 94-98 (Pubitemid 36834848)
21. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302, 1056-1060 (Pubitemid 37386201)
22. Jager, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., Mahon, C., Kane, J., Franks-Skiba, K., Cimermancic, P., Burlingame, A., Sali, A., Craik, C. S., Harris, R. S., Gross, J. D., and Krogan, N. J. (2012) Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection Nature 481, 371-375
23. Zhang, W., Du, J., Evans, S. L., Yu, Y., and Yu, X. F. (2012) T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction Nature 481, 376-379
24. Conticello, S. G., Harris, R. S., and Neuberger, M. S. (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13, 2009-2013 (Pubitemid 37425213)
25. Kobayashi, M., Takaori-Kondo, A., Miyauchi, Y., Iwai, K., and Uchiyama, T. (2005) Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function J. Biol. Chem. 280, 18573-18578 (Pubitemid 41379555)
26. Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9, 1398-1403 (Pubitemid 37466189)
27. Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., and Gabuzda, D. (2004) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279, 7792-7798 (Pubitemid 38294663)
28. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12, 591-601 (Pubitemid 37222482)
29. Chen, G., He, Z., Wang, T., Xu, R., and Yu, X. F. (2009) A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G J. Virol. 83, 8674-8682
30. Dang, Y., Davis, R. W., York, I. A., and Zheng, Y. H. (2010) Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity J. Virol. 84, 5741-5750
31. Dang, Y., Wang, X., Zhou, T., York, I. A., and Zheng, Y. H. (2009) Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization J. Virol. 83, 8544-8552
32. He, Z., Zhang, W., Chen, G., Xu, R., and Yu, X. F. (2008) Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction J. Mol. Biol. 381, 1000-1011
33. Pery, E., Rajendran, K. S., Brazier, A. J., and Gabuzda, D. (2009) Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif J. Virol. 83, 2374-2381
34. Russell, R. A. and Pathak, V. K. (2007) Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F J. Virol. 81, 8201-8210 (Pubitemid 47101506)
35. Schrofelbauer, B., Senger, T., Manning, G., and Landau, N. R. (2006) Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G J. Virol. 80, 5984-5991 (Pubitemid 43849176)
36. Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., and Gabuzda, D. (2004) Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation Genes Dev. 18, 2861-2866 (Pubitemid 39602304)
37. Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X., and Yu, X. F. (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines Genes Dev. 18, 2867-2872 (Pubitemid 39602305)
38. Luo, K., Xiao, Z., Ehrlich, E., Yu, Y., Liu, B., Zheng, S., and Yu, X. F. (2005) Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G Proc. Natl. Acad. Sci. U.S.A. 102, 11444-11449 (Pubitemid 41153839)
39. Mehle, A., Thomas, E. R., Rajendran, K. S., and Gabuzda, D. (2006) A zinc-binding region in Vif binds Cul5 and determines cullin selection J. Biol. Chem. 281, 17259-17265
40. Xiao, Z., Ehrlich, E., Yu, Y., Luo, K., Wang, T., Tian, C., and Yu, X. F. (2006) Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif Virology 349, 290-299 (Pubitemid 43782879)
41. 2+ Site in HIV-1 Vif Biochemistry 48, 7969-7978
42. Paul, I., Cui, J., and Maynard, E. L. (2006) Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions Proc. Natl. Acad. Sci. U.S.A. 103, 18475-18480 (Pubitemid 44913435)
43. Stanley, B. J., Ehrlich, E. S., Short, L., Yu, Y., Xiao, Z., Yu, X. F., and Xiong, Y. (2008) Structural Insight into the HIV Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly J. Virol. 82, 8656-8663
44. Wolfe, L. S., Stanley, B. J., Liu, C., Eliason, W. K., and Xiong, Y. (2010) Dissection of HIV Vif interaction with the human E3 ubiquitin ligase J. Virol. 84, 7135-7139
45. Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., Conaway, R. C., Conaway, J. W., and Nakayama, K. I. (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases Genes Dev. 18, 3055-3065 (Pubitemid 39658174)
46. Bergeron, J. R., Huthoff, H., Veselkov, D. A., Beavil, R. L., Simpson, P. J., Matthews, S. J., Malim, M. H., and Sanderson, M. R. (2010) The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex PLoS Pathog. 6, e1000925
47. Donahue, J. P., Vetter, M. L., Mukhtar, N. A., and D'Aquila, R. T. (2008) The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation Virology 377, 49-53
48. Walker, R. C., Jr., Khan, M. A., Kao, S., Goila-Gaur, R., Miyagi, E., and Strebel, K. (2010) Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif J. Virol. 84, 5201-5211
49. Auclair, J. R., Green, K. M., Shandilya, S., Evans, J. E., Somasundaran, M., and Schiffer, C. A. (2007) Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity Proteins 69, 270-284 (Pubitemid 47429290)
50. Marcsisin, S. R. and Engen, J. R. (2010) Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif J. Mol. Biol. 402, 892-904
51. Yang, S., Sun, Y., and Zhang, H. (2001) The multimerization of human immunodeficiency virus type I Vif protein: A requirement for Vif function in the viral life cycle J. Biol. Chem. 276, 4889-4893
52. Yang, B., Gao, L., Li, L., Lu, Z., Fan, X., Patel, C. A., Pomerantz, R. J., DuBois, G. C., and Zhang, H. (2003) Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins J. Biol. Chem. 278, 6596-6602 (Pubitemid 36800923)
53. Miller, J. H., Presnyak, V., and Smith, H. C. (2007) The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G Retrovirology 4, 81
54. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., and Gray, T. (1995) How to measure and predict the molar absorption coefficient of a protein Protein Sci. 4, 2411-2423
55. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling Biophys. J. 78, 1606-1619 (Pubitemid 30141584)
56. Cole, J. L., Lary, J. W., P Moody, T., and Laue, T. M. (2008) Analytical ultracentrifugation: Sedimentation velocity and sedimentation equilibrium Methods Cell Biol. 84, 143-179
57. Provencher, S. W. and Glockner, J. (1981) Estimation of globular protein secondary structure from circular dichroism Biochemistry 20, 33-37
58. Lees, J. G., Smith, B. R., Wien, F., Miles, A. J., and Wallace, B. A. (2004) CDtool: An integrated software package for circular dichroism spectroscopic data processing, analysis, and archiving Anal. Biochem. 332, 285-289 (Pubitemid 39485737)
59. Lobley, A., Whitmore, L., and Wallace, B. A. (2002) DICHROWEB: An interactive website for the analysis of protein secondary structure from circular dichroism spectra Bioinformatics 18, 211-212 (Pubitemid 34145057)
60. Whitmore, L. and Wallace, B. A. (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32, W668-W673
61. Bernacchi, S., Mercenne, G., Tournaire, C., Marquet, R., and Paillart, J. C. (2011) Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif Nucleic Acids Res. 39, 2404-2415
62. Henriet, S., Richer, D., Bernacchi, S., Decroly, E., Vigne, R., Ehresmann, B., Ehresmann, C., Paillart, J. C., and Marquet, R. (2005) Cooperative and specific binding of Vif to the 5′ region of HIV-1 genomic RNA J. Mol. Biol. 354, 55-72 (Pubitemid 41527214)
63. Bernacchi, S., Henriet, S., Dumas, P., Paillart, J. C., and Marquet, R. (2007) RNA and DNA binding properties of HIV-1 Vif protein: A fluorescence study J. Biol. Chem. 282, 26361-26368 (Pubitemid 47443766)
64. Zhao, H., Brown, P. H., Balbo, A., Fernandez-Alonso Mdel, C., Polishchuck, N., Chaudhry, C., Mayer, M. L., Ghirlando, R., and Schuck, P. (2010) Accounting for solvent signal offsets in the analysis of interferometric sedimentation velocity data Macromol. Biosci. 10, 736-745
65. Buck, M. (1998) Trifluoroethanol and colleagues: Cosolvents come of age. Recent studies with peptides and proteins Q. Rev. Biophys. 31, 297-355 (Pubitemid 29213772)
66. Kao, S., Goila-Gaur, R., Miyagi, E., Khan, M. A., Opi, S., Takeuchi, H., and Strebel, K. (2007) Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif Virology 369, 329-339 (Pubitemid 350087192)
67. Giri, K. and Maynard, E. L. (2009) Conformational analysis of a peptide approximating the HCCH motif in HIV-1 Vif Pept. Sci. 92, 417-425
68. Yang, X., Goncalves, J., and Gabuzda, D. (1996) Phosphorylation of Vif and its role in HIV-1 replication J. Biol. Chem. 271, 10121-10129 (Pubitemid 26131573)
69. Chiu, Y. L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., and Greene, W. C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Nature 435, 108-114 (Pubitemid 40655917)